SUPPORTING PARTNERS

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

Perci's mission is to proactively challenge the current status quo for those living with cancer and change perceptions about life after treatment. We are an online platform offering access to multiple cancer-related support types in one accessible location, available within 1-2 days of booking. 

 

We consider recovery from a whole-person perspective: psychological, physical, social and emotional. Our professionals cover a wide range of support including psychosexual therapy, speech and language therapy, menopause advice (and much more), and come carefully vetted with a minimum of 3-years cancer experience. 

 

We are part of a wide network of organisations trying to solve the issues faced by the growing population of people affected by cancer. Ensuring no treatable side-effect goes untreated.

Chemotherapy-induced hair loss is widely recognised as the most feared side effect associated with cancer treatment. It is often the first question that people ask when they learn they will require chemotherapy, “Will I lose my hair?”  

 

Paxman is a British medical technology company whose scalp cooling device, available in over 95% of UK hospitals, empowers patients to feel a greater sense of control in helping them to reduce hair loss.

 

Paxman is delighted to work with The Leanne Pero Foundation, and is committed to continuing its efforts to make sure that all voices are heard, particularly those of women of colour, who have been cut out of so many important conversations over the years.

 

 Speaking about the partnership, Claire Paxman, Director of Training & Strategic Initiatives, commented, “Paxman is committed to promote equality in all parts of its business. The company supports and is strongly committed to promote equality within not only race and colour, but also religion, sexuality, gender and opportunity.

We truly believe a person's life and health options should not be determined by the colour of their skin.”

Many patients rank hair loss as the most feared and traumatic side effect of their cancer treatment, it can lead to social isolation and the psychological effect is high often having a dramatic impact on self-esteem. Find out more: www.coldcap.com